Research graph
References from Nueva era terapéutica en la obesidad infantojuvenil: oportunidades y retos de futuro. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2022 · External reference
Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity
10.2337/dci24-0003 · 2024 · External reference
A randomized, controlled trial of liraglutide for adolescents with obesity
10.1056/nejmoa1916038 · 2020 · External reference
Once-weekly semaglutide in adolescents with obesity
10.1056/nejmoa2208601 · 2022 · External reference
Unintended consequences of obesity pharmacotherapy: A nutritional approach to ensuring better patient outcomes
10.3390/nu17111934 · 2025 · External reference
